SALUS Ljubljana d. d (SALR) Stock Overview
Engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
SALR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
SALUS, Ljubljana, d. d. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €70.00 |
| 52 Week High | €72.00 |
| 52 Week Low | €27.95 |
| Beta | 0.54 |
| 1 Month Change | 33.33% |
| 3 Month Change | 44.03% |
| 1 Year Change | 150.46% |
| 3 Year Change | 287.23% |
| 5 Year Change | 465.80% |
| Change since IPO | 6,371.95% |
Recent News & Updates
Recent updates
SALUS, Ljubljana, d. d.'s (LJSE:SALR) 29% Jump Shows Its Popularity With Investors
Sep 09
Increases to CEO Compensation Might Be Put On Hold For Now at SALUS, Ljubljana, d. d. (LJSE:SALR)
Apr 11SALUS Ljubljana d. d (LJSE:SALR) Is Due To Pay A Dividend Of €35.00
Mar 14SALUS, Ljubljana, d. d.'s (LJSE:SALR) 28% Price Boost Is Out Of Tune With Earnings
Feb 06SALUS Ljubljana d. d (LJSE:SALR) Will Pay A Dividend Of €35.00
Dec 30SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Apr 05We Think You Should Be Aware Of Some Concerning Factors In SALUS Ljubljana d. d's (LJSE:SALR) Earnings
Mar 22SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Mar 12SALUS Ljubljana d. d (LJSE:SALR) Has A Pretty Healthy Balance Sheet
Sep 21We Like These Underlying Return On Capital Trends At SALUS Ljubljana d. d (LJSE:SALR)
Jun 02With EPS Growth And More, SALUS Ljubljana d. d (LJSE:SALR) Is Interesting
May 13These 4 Measures Indicate That SALUS Ljubljana d. d (LJSE:SALR) Is Using Debt Reasonably Well
Apr 22Shareholders Of SALUS Ljubljana d. d (LJSE:SALR) Must Be Happy With Their 274% Total Return
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In SALUS, Ljubljana, d. d.'s LJSE:SALR) Stock?
Feb 12
The Price Is Right For SALUS, Ljubljana, d. d. (LJSE:SALR)
Jan 26There's A Lot To Like About SALUS Ljubljana d. d's (LJSE:SALR) Upcoming €25.00 Dividend
Jan 07SALUS Ljubljana d. d (LJSE:SALR) Seems To Use Debt Rather Sparingly
Dec 24How Does SALUS, Ljubljana, d. d. (LJSE:SALR) Fare As A Dividend Stock?
Dec 02Shareholder Returns
| SALR | SI Healthcare | SI Market | |
|---|---|---|---|
| 7D | 7.7% | -5.3% | -4.5% |
| 1Y | 150.5% | 5.9% | 41.6% |
Return vs Industry: SALR exceeded the SI Healthcare industry which returned 5.9% over the past year.
Return vs Market: SALR exceeded the SI Market which returned 41.6% over the past year.
Price Volatility
| SALR volatility | |
|---|---|
| SALR Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in SI Market | 6.8% |
| 10% least volatile stocks in SI Market | 3.2% |
Stable Share Price: SALR's share price has been volatile over the past 3 months compared to the SI market.
Volatility Over Time: SALR's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of SI stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 618 | Ziga Hieng | www.salus.si |
SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institutions, and other customers. It also provides value-added services, such as specialized services, storage and transport, destruction, authentication of medicines, secondary packaging, regulatory services, pharmacovigilance and vigilance of medical devices, pharmacoeconomics, and marketing communication.
SALUS, Ljubljana, d. d. Fundamentals Summary
| SALR fundamental statistics | |
|---|---|
| Market cap | €575.35m |
| Earnings (TTM) | €14.48m |
| Revenue (TTM) | €673.54m |
Is SALR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SALR income statement (TTM) | |
|---|---|
| Revenue | €673.54m |
| Cost of Revenue | €593.95m |
| Gross Profit | €79.59m |
| Other Expenses | €65.11m |
| Earnings | €14.48m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.76 |
| Gross Margin | 11.82% |
| Net Profit Margin | 2.15% |
| Debt/Equity Ratio | 20.7% |
How did SALR perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/09 07:51 |
| End of Day Share Price | 2026/03/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SALUS, Ljubljana, d. d. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.